Effect of Edaravone Combined with Anticoagulant Therapy on the Serum hs-CRP, IL-6, and TNF-α Levels and Activity of Daily Living in Patients with Acute Cerebral Infarction

Figure 1

Comparison of platelet-activating factors after treatment (mean ± SD). (a) comparison of PMA levels after treatment. The abscissa represented the routine group and combined group, and the ordinate represented the PMA level (%). The average PMA levels of the routine group and combined group after treatment were (21.42 ± 2.42) % and (17.72 ± 2.00) %. ^∗ indicated a notable difference in the average PMA levels between the two groups after treatment (t = 7.638, ). (b) Comparison of CD62p levels after treatment. The abscissa represented the routine group and combined group, and the ordinate represented the CD62p level (%). The average CD62p levels of the routine group and combined group after treatment were (2.56 ± 0.20) % and (1.29 ± 0.19) %. ^∗∗ indicated a notable difference in the average CD62p levels between the two groups after treatment (t = 29.836, ).

(a)

(b)